Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 1.389
Filtrer
1.
Article de Russe | MEDLINE | ID: mdl-38349680

RÉSUMÉ

The modern health care is characterized by constant increasing need in laboratory tests. The quality and accessibility of laboratory diagnostics becomes one of key determinants of social well-being in aspect of maintaining population health. The purpose of the study is in developing system of criteria and indicators of accessibility of laboratory diagnostics applicable in organization of health care at the level of the Subject of the Russian Federation. The methods. The study was carried out based on principles of system approach. The methodological approach developed by Professor O. Yu. Alexandrova was applied. The analytical research methods (analysis, synthesis) were implemented. The results and discussion. The set of criteria, including three groups of measurable indicators, applicable in the field of laboratory diagnostics was developed. The original approach to determine time indicators of laboratory tests accessibility was proposed. The system can be applied as organizational technology permitting to establish specific requirements for laboratory diagnostics accessibility at the level of the Subject of the Russian Federation. These requirements can be included in local normative legal acts. The conclusions. The developed system of criteria and indicators of laboratory diagnostics accessibility can be used in development of medical care system that meets the best of characteristics and needs of particular Subject of the Russian Federation.


Sujet(s)
Laboratoires , Santé de la population , Établissements de santé , Russie , Plan de recherche
2.
Climacteric ; 27(1): 47-52, 2024 Feb.
Article de Anglais | MEDLINE | ID: mdl-38073517

RÉSUMÉ

Polycystic ovary syndrome (PCOS), characterized by abnormal menstrual periods, elevated androgen levels and polycystic ovary morphology on ultrasound, is the most common endocrine disorder among females. PCOS is associated with cardiovascular disease (CVD) risk factors including diabetes, obesity, metabolic syndrome, adverse pregnancy outcomes such as pre-eclampsia and psychosocial distress including depression. Previous evidence on the association between PCOS and CVD is inconclusive but the latest 2023 International Evidence-Based PCOS Guideline identifies PCOS as a risk factor for CVD. This review will discuss the relationship between PCOS and CVD along with current direction for CVD screening and prevention among individuals with PCOS.


Sujet(s)
Maladies cardiovasculaires , Diabète , Syndrome métabolique X , Syndrome des ovaires polykystiques , Grossesse , Femelle , Humains , Syndrome des ovaires polykystiques/complications , Maladies cardiovasculaires/prévention et contrôle , Facteurs de risque , Syndrome métabolique X/complications
3.
Ann R Coll Surg Engl ; 105(7): 645-652, 2023 Sep.
Article de Anglais | MEDLINE | ID: mdl-37652085

RÉSUMÉ

INTRODUCTION: There are large variations in the number of hip replacements performed between countries, demonstrating large health inequalities; however, there has been limited research on this variation. The aims of this paper were to compare rates of hip replacements using Organisation for Economic Co-operation and Development (OECD) data for the period 2008-2018. The study also compared changes in the number of hip replacements in the total population and in only those aged over 65, and looked for a correlation of health expenditure and gross domestic product (GDP) with rates of hip replacements. METHODS: The OECD collects annual data from all member countries on the numbers of hip replacements, healthcare expenditure and GDP. Data analysis was undertaken using STATA. Descriptive statistics and Pearson's correlation coefficient were performed. RESULTS: The mean number of hip replacements performed in OECD countries in 2018 was 191.5 per 100,000 population per year. The largest number was 310.6 in Germany and the lowest was 8.6 in Mexico. There has been a 21.7% increase in the mean number of hip replacements across OECD countries. There was a moderate and significant Pearson coefficient of 0.468 (p = 0.009) between the number of hip replacements performed per 100,000 population in 2018 and GDP per person, and a strong and significant correlation with health expenditure (R = 0.784, p < 0.001). There was a moderate correlation (R = 0.645, p = 0.003) between the percentage change in the number of hip replacements performed per 100,000 population and the percentage change in healthcare expenditure per person between 2008 and 2018. CONCLUSIONS: There is 36-fold variation in the practice of hip replacements across the OECD and the number of hip replacements has increased by more than 20% over the past decade. The number of hip replacements performed appears to be correlated with health expenditure in each country and may indicate a need that can only be met by increasing health expenditure.


Sujet(s)
Arthroplastie prothétique de hanche , Humains , Sujet âgé , Organisation de coopération et de développement économiques
4.
ESMO Open ; 7(6): 100648, 2022 12.
Article de Anglais | MEDLINE | ID: mdl-36462463

RÉSUMÉ

BACKGROUND: An effect of non-oncology medications on cancer outcome has been proposed. In this study, we aimed to systematically examine the impact of commonly prescribed non-oncology drugs on clinical risk and on the genomic risk [based on the Oncotype DX recurrence score (RS)] in early breast cancer (BC). EXPERIMENTAL DESIGN: We collected data on clinical risk (stage and grade), genomic risk (Oncotype DX RS), and on non-oncology medications administered to 1423 patients with estrogen receptor-positive human epidermal growth factor receptor 2-negative BC during the month of their surgery. The influence of various medications on clinical and genomic risks was evaluated by statistical analysis. RESULTS: Out of the multiple drugs we examined, levothyroxine was significantly associated with a high Oncotype DX RS (mean 24.78; P < 0.0001) and metformin with a low Oncotype DX RS (mean 14.87; P < 0.01) compared with patients not receiving other non-oncology drugs (mean 18.7). By contrast, there were no differences in the clinical risk between patients receiving metformin, levothyroxine, or no other non-oncology drugs. Notably, there was no association between the consumption of levothyroxine and metformin and proliferation marker (Ki67) levels, but both drugs were significantly associated with progesterone-related features, suggesting that they influence genomic risk through estrogen-dependent signaling. CONCLUSIONS: The results of this study indicate a significant impact of metformin and levothyroxine on clinical decisions in luminal BC, with potential impact on the clinical course of these patients.


Sujet(s)
Tumeurs du sein , Metformine , Humains , Femelle , Tumeurs du sein/traitement médicamenteux , Tumeurs du sein/génétique , Tumeurs du sein/métabolisme , Thyroxine , Récidive tumorale locale/génétique , Génomique
5.
Article de Russe | MEDLINE | ID: mdl-35670405

RÉSUMÉ

The modern trends in health care (strategies of optimizing costs, value-oriented medical care) require systematic development of laboratory services for administrative territories. The study was carried out to provide support for decision-making by systematizing models of laboratory services on the basis of principles of systematic approach. Four basic models (centralization, outsourcing, horizontal integration, point-of-care) were analyzed. The study applied such research methods as analytical and strategic SWOT-analysis. The SWOT-analysis was implemented using list of standard characteristics for each model of laboratory service organization. Each model is distinguished by complex combination of strengths, weaknesses, lines of functioning and development. The availability of implementing particular model depends on delicate balance of opportunities and risks against the background of local characteristics of administrative subject. The dynamics of the social economic and infrastructural development of administrative subject can significantly affect effectiveness of model implementation. The objective set of characteristics was obtained for each model of laboratory service organization. Actually it is impossible to select particular model for specific administrative subject. Hence, scientific substantiation of "flexible" model is needed to implement.


Sujet(s)
Prestations des soins de santé , Modèles d'organisation , Services de diagnostic
6.
Bull Exp Biol Med ; 168(2): 275-279, 2019 Dec.
Article de Anglais | MEDLINE | ID: mdl-31782001

RÉSUMÉ

We studied the effects of combined chemotherapy with doxorubicin/docetaxel on erythroid and granulocytic hematopoietic lineages with particular attention focused on their recovery in patients with stages III-IV breast cancer. Intensification of differentiation of erythroid and granulocytic CFU (even under conditions of their suppressed proliferation) provided the increase in the content of mature and morphologically differentiated elements in the bone marrow and peripheral blood. High proliferative activity of erythroid and granulomonocytic precursors resulted from enhanced production of hematopoiesis-stimulating activities by microenvironment elements.


Sujet(s)
Antinéoplasiques/usage thérapeutique , Tumeurs du sein/traitement médicamenteux , Docetaxel/usage thérapeutique , Doxorubicine/usage thérapeutique , Érythropoïèse/effets des médicaments et des substances chimiques , Leucopoïèse/effets des médicaments et des substances chimiques , Protocoles de polychimiothérapie antinéoplasique/usage thérapeutique , Moelle osseuse/métabolisme , Lignage cellulaire/effets des médicaments et des substances chimiques , Érythrocytes/cytologie , Femelle , Facteur de stimulation des colonies de granulocytes/métabolisme , Granulocytes/cytologie , Humains
7.
Bone Joint J ; 101-B(3): 348-352, 2019 Mar.
Article de Anglais | MEDLINE | ID: mdl-30813789

RÉSUMÉ

AIMS: Cone beam CT allows cross-sectional imaging of the tibiofibular syndesmosis while the patient bears weight. This may facilitate more accurate and reliable investigation of injuries to, and reconstruction of, the syndesmosis but normal ranges of measurements are required first. The purpose of this study was to establish: 1) the normal reference measurements of the syndesmosis; 2) if side-to-side variations exist in syndesmotic anatomy; 3) if age affects syndesmotic anatomy; and 4) if the syndesmotic anatomy differs between male and female patients in weight-bearing cone beam CT views. PATIENTS AND METHODS: A retrospective analysis was undertaken of 50 male and 50 female patients (200 feet) aged 18 years or more, who underwent bilateral, simultaneous imaging of their lower legs while standing in an upright, weight-bearing position in a pedCAT machine between June 2013 and July 2017. At the time of imaging, the mean age of male patients was 47.1 years (18 to 72) and the mean age of female patients was 57.8 years (18 to 83). We employed a previously described technique to obtain six lengths and one angle, as well as calculating three further measurements, to provide information on the relationship between the fibula and tibia with respect to translation and rotation. RESULTS: The upper limit of lateral translation in un-injured patients was 5.27 mm, so values higher than this may be indicative of syndesmotic injury. Anteroposterior translation lay within the ranges 0.31 mm to 2.59 mm, and -1.48 mm to 3.44 mm, respectively. There was no difference between right and left legs. Increasing age was associated with a reduction in lateral translation. The fibulae of men were significantly more laterally translated but data were inconsistent for rotation and anteroposterior translation. CONCLUSION: We have established normal ranges for measurements in cross-sectional syndesmotic anatomy during weight-bearing and also established that no differences exist between right and left legs in patients without syndesmotic injury. Age and gender do, however, affect the anatomy of the syndesmosis, which should be taken into account at time of assessment. Cite this article: Bone Joint J 2019;101-B:348-352.


Sujet(s)
Articulation talocrurale/imagerie diagnostique , Tomodensitométrie à faisceau conique , Mise en charge , Adolescent , Adulte , Facteurs âges , Sujet âgé , Sujet âgé de 80 ans ou plus , Anatomie en coupes transversales , Articulation talocrurale/anatomie et histologie , Articulation talocrurale/physiologie , Poids et mesures du corps/normes , Femelle , Fibula/anatomie et histologie , Fibula/imagerie diagnostique , Humains , Mâle , Adulte d'âge moyen , Valeurs de référence , Études rétrospectives , Facteurs sexuels , Tibia/anatomie et histologie , Tibia/imagerie diagnostique , Jeune adulte
8.
Bull Exp Biol Med ; 166(1): 63-68, 2018 Nov.
Article de Anglais | MEDLINE | ID: mdl-30450524

RÉSUMÉ

We studied myelotoxicity of modern schemes of chemotherapy for breast cancer (docetaxel/doxorubicin and cyclophosphamide/doxorubicin/5-fluorouracil) towards granulocytopoiesis, the mechanisms determining the differences of hematological effects of these schemes, and the efficiency of correction of the observed changes with granulocyte CSF (filgrastim). Granulocytopoiesis stimulation with filgrastim during the treatment with docetaxel/doxorubicin combination was more pronounced than during cyclophosphamide/doxorubicin/5-fluorouracil therapy. The observed differences were found at all levels of granulocyte lineage organization (central and peripheral), which is related to different effects of the cytostatic substances used in the proposed protocols on the structures controlling hemopoiesis.


Sujet(s)
Tumeurs du sein/traitement médicamenteux , Tumeurs du sein/métabolisme , Filgrastim/usage thérapeutique , Granulocytes/cytologie , Granulocytes/effets des médicaments et des substances chimiques , Cyclophosphamide/usage thérapeutique , Doxorubicine/usage thérapeutique , Femelle , Fluorouracil/usage thérapeutique , Facteur de stimulation des colonies de granulocytes/métabolisme , Humains
9.
Bone Joint J ; 100-B(7): 945-952, 2018 07.
Article de Anglais | MEDLINE | ID: mdl-29954204

RÉSUMÉ

Aims: Gastrocnemius tightness predisposes to musculoskeletal pathology and may require surgical treatment. However, it is not clear what proportion of patients with foot and ankle pathology have clinically significant gastrocnemius tightness. The aim of this study was to compare the prevalence and degree of gastrocnemius tightness in a control group of patients with a group of patients with foot and ankle pathology. Patients and Methods: This prospective, case-matched, observational study compared gastrocnemius tightness, as assessed by the lunge test, in a control group and a group with foot and ankle pathology. Gastrocnemius tightness was calculated as the difference in dorsiflexion of the ankle with the knee extended and flexed. Results: A total of 291 controls were paired with 97 patients with foot and ankle pathology (FAP). The mean gastrocnemius tightness was 6.0° (sd 3.5) in controls and 8.0° (sd 5.7) in the FAP group (p < 0.001). Subgroup analysis showed a mean gastrocnemius tightness of 10.3° (sd 6.0) in patients with forefoot pathology versus 6.9° (sd 5.3) in patients with other pathology (p = 0.008). A total of 12 patients (37.5%) with forefoot pathology had gastrocnemius tightness of > two standard deviations of the control group (> 13°). Conclusion: Gastrocnemius tightness of > 13° may be considered abnormal. Most patients with foot and ankle pathology do not have abnormal degrees of gastrocnemius tightness compared with controls, but it is present in over a third of patients with forefoot pathology. Cite this article: Bone Joint J 2018;100-B:945-52.


Sujet(s)
Articulation talocrurale/anatomopathologie , Contracture/épidémiologie , Maladies du pied/complications , Tonus musculaire , Adulte , Études cas-témoins , Contracture/étiologie , Femelle , Pied/anatomopathologie , Humains , Mâle , Adulte d'âge moyen , Muscles squelettiques , Prévalence , Études prospectives , Amplitude articulaire , Royaume-Uni
10.
Nat Commun ; 9(1): 1709, 2018 04 27.
Article de Anglais | MEDLINE | ID: mdl-29703975

RÉSUMÉ

The acquisition of genes by horizontal transfer can impart entirely new biological functions and provide an important route to major evolutionary innovation. Here we have used ancient gene reconstruction and functional assays to investigate the impact of a single horizontally transferred nucleotide transporter into the common ancestor of the Microsporidia, a major radiation of intracellular parasites of animals and humans. We show that this transporter provided early microsporidians with the ability to steal host ATP and to become energy parasites. Gene duplication enabled the diversification of nucleotide transporter function to transport new substrates, including GTP and NAD+, and to evolve the proton-energized net import of nucleotides for nucleic acid biosynthesis, growth and replication. These innovations have allowed the loss of pathways for mitochondrial and cytosolic energy generation and nucleotide biosynthesis that are otherwise essential for free-living eukaryotes, resulting in the highly unusual and reduced cells and genomes of contemporary Microsporidia.


Sujet(s)
Évolution moléculaire , Transfert horizontal de gène , Interactions hôte-pathogène/génétique , Microsporidia/génétique , Transporteurs de nucléotides/génétique , Animaux , Lignée cellulaire , Duplication de gène , Génome fongique/génétique , Voies et réseaux métaboliques/génétique , Microsporidia/métabolisme , Transporteurs de nucléotides/métabolisme , Nucléotides/métabolisme , Phylogenèse , Lapins
11.
Foot Ankle Surg ; 24(4): 314-319, 2018 Aug.
Article de Anglais | MEDLINE | ID: mdl-29409245

RÉSUMÉ

BACKGROUND: Little is understood about the role that relative sesamoid displacement and chondral wear have on outcome after hallux valgus (HV) surgery. All existing methods to evaluate relative sesamoid displacement have limitations and furthermore, there have been no radiographic studies evaluating metatarso-sesamoid joint wear. Standing CT scan circumvents many of the existing problems in evaluation of relative sesamoid displacement, and also enables the first radiographic study assessing metatarso-sesamoid joint wear. METHODS: Fifty feet (in 43 patients) with symptomatic HV (Group A) were compared with a control group of 50 feet (50 patients) (Group B). All images were standardised to enable reproducible measurements. The hallux valgus angle, Intermetatarsal angle, sesamoid rotation angle, sesamoid position and metatarso-sesamoid joint space were measured in all patients. RESULTS: The intra and inter-observer reliability correlation showed that the standing CT assessment of sesamoid position (1.000), rotation (0.991) and metatarso-sesamoid joint space (0.960) were highly reproducible. There was a highly significant difference (p<0.0001) in sesamoid position, sesamoid rotation and metatarso-sesamoid joint space between Group A and Group B. CONCLUSIONS: Standing CT has been shown to be a reproducible and accurate method of assessing the relative sesamoid displacement and metatarso-sesamoid joint space narrowing. The results have been used to propose a novel standing CT based classification of hallucal sesamoids, considering the degree of displacement and wear. This classification may ultimately facilitate research to provide new insight into the effect relative sesamoid displacement and chondral wear have on outcomes from hallux valgus surgery.


Sujet(s)
Hallux valgus/imagerie diagnostique , Hallux/imagerie diagnostique , Os sésamoïdes/imagerie diagnostique , Articulation de l'orteil/imagerie diagnostique , Tomodensitométrie/méthodes , Adolescent , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Femelle , Hallux/chirurgie , Hallux valgus/classification , Hallux valgus/chirurgie , Humains , Mâle , Adulte d'âge moyen , Reproductibilité des résultats , Os sésamoïdes/chirurgie , Position debout , Articulation de l'orteil/chirurgie , Jeune adulte
12.
J Perinatol ; 37(12): 1315-1318, 2017 12.
Article de Anglais | MEDLINE | ID: mdl-29192695

RÉSUMÉ

OBJECTIVE: We constructed a transcutaneous bilirubin (TcB) nomogram to represent major sectors of the Israeli population. We studied the risk of hyperbilirubinemia, defined as meeting the requirements for phototherapy, per percentile risk category. STUDY DESIGN: Newborns ⩾36 weeks gestation were tested daily for TcB, using Drager JM-103 devices, during birth hospitalization. A nomogram was constructed and divided into four risk groups and validated by calculating the need for phototherapy for each group. RESULTS: A total of 3303 measurements were performed on 1059 consecutive newborns including Ashkenazi, Sephardic and mixed Ashkenazi/Sephardic Jews, Arab and Ethiopian Jewish. Phototherapy risk increased progressively and more than 100-fold, from 0/225 in the <40th percentile group through 27/120 (22.5%) for those >95th percentile (relative risk (95% confidence interval) 102 (6 to 1669) for those >95th percentile compared with those <40th percentile). The optimal risk for discriminating the need for phototherapy was >75th percentile (sensitivity 93.33, specificity 59.47). CONCLUSION: The risk of significant hyperbilirubinemia increased progressively with increasing percentile. Newborns >75th percentile groups are at high risk for phototherapy and should be closely monitored.


Sujet(s)
Bilirubine/sang , Hyperbilirubinémie néonatale/diagnostic , Nomogrammes , Arabes , Marqueurs biologiques/sang , Éthiopie/ethnologie , Femelle , Humains , Hyperbilirubinémie néonatale/sang , Hyperbilirubinémie néonatale/ethnologie , Hyperbilirubinémie néonatale/thérapie , Nouveau-né , Israël , Juif , Mâle , Dépistage néonatal/méthodes , Photothérapie/statistiques et données numériques , Valeur prédictive des tests , Facteurs de risque
13.
Pediatr. crit. care med ; 18(11): 1035-1046, nov. 2017.
Article de Anglais | BIGG - guides GRADE | ID: biblio-965150

RÉSUMÉ

OBJECTIVES: Create trustworthy, rigorous, national clinical practice guidelines for the practice of pediatric donation after circulatory determination of death in Canada. METHODS: We followed a process of clinical practice guideline development based on World Health Organization and Canadian Medical Association methods. This included application of Grading of Recommendations Assessment, Development, and Evaluation methodology. Questions requiring recommendations were generated based on 1) 2006 Canadian donation after circulatory determination of death guidelines (not pediatric specific), 2) a multidisciplinary symposium of national and international pediatric donation after circulatory determination of death leaders, and 3) a scoping review of the pediatric donation after circulatory determination of death literature. Input from these sources drove drafting of actionable questions and Good Practice Statements, as defined by the Grading of Recommendations Assessment, Development, and Evaluation group. We performed additional literature reviews for all actionable questions. Evidence was assessed for quality using Grading of Recommendations Assessment, Development, and Evaluation and then formulated into evidence profiles that informed recommendations through the evidence-to-decision framework. Recommendations were revised through consensus among members of seven topic-specific working groups and finalized during meetings of working group leads and the planning committee. External review was provided by pediatric, critical care, and critical care nursing professional societies and patient partners. RESULTS: We generated 63 Good Practice Statements and seven Grading of Recommendations Assessment, Development, and Evaluation recommendations covering 1) ethics, consent, and withdrawal of life-sustaining therapy, 2) eligibility, 3) withdrawal of life-sustaining therapy practices, 4) ante and postmortem interventions, 5) death determination, 6) neonatal pediatric donation after circulatory determination of death, 7) cardiac and innovative pediatric donation after circulatory determination of death, and 8) implementation. For brevity, 48 Good Practice Statement and truncated justification are included in this summary report. The remaining recommendations, detailed methodology, full Grading of Recommendations Assessment, Development, and Evaluation tables, and expanded justifications are available in the full text report. CONCLUSIONS: This process showed that rigorous, transparent clinical practice guideline development is possible in the domain of pediatric deceased donation. Application of these recommendations will increase access to pediatric donation after circulatory determination of death across Canada and may serve as a model for future clinical practice guideline development in deceased donation


Sujet(s)
Humains , Nouveau-né , Enfant d'âge préscolaire , Enfant , Adolescent , Donneurs de tissus , Acquisition d'organes et de tissus , Mort , Soins terminaux/méthodes , Soins terminaux/normes , Acquisition d'organes et de tissus/méthodes , Acquisition d'organes et de tissus/normes , Acquisition d'organes et de tissus/éthique , Canada , Abstention thérapeutique/normes , Consentement libre et éclairé
14.
Bull Exp Biol Med ; 163(4): 469-474, 2017 Aug.
Article de Anglais | MEDLINE | ID: mdl-28853075

RÉSUMÉ

The toxic effects of combined cisplatin/docetaxel therapy cycles on erythroid and granulocytic hematopoietic lineages as well as their intercycle recovery were examined in patients with stage III-IV non-small-cell lung carcinoma. Responsiveness of the blood system to this therapy remained at a high level. Combined therapy pronouncedly activated the key elements of the erythroid and granulocytic hematopoietic lineages leading to accumulation of immature and mature myelokaryocytes in the bone marrow, enlargement of the medullary pool of mature neutrophils, and increase in the count of medullary erythroid and granulocytic precursor cells under conditions of their accelerated maturation.


Sujet(s)
Carcinome pulmonaire non à petites cellules/métabolisme , Granulocytes/métabolisme , Tumeurs du poumon/métabolisme , Anthracyclines/pharmacologie , Antinéoplasiques/pharmacologie , Différenciation cellulaire/effets des médicaments et des substances chimiques , Cisplatine/pharmacologie , Diholoside/pharmacologie , Docetaxel , Doxorubicine/pharmacologie , Érythropoïèse/effets des médicaments et des substances chimiques , Granulocytes/cytologie , Granulocytes/effets des médicaments et des substances chimiques , Cellules souches hématopoïétiques/effets des médicaments et des substances chimiques , Cellules souches hématopoïétiques/métabolisme , Humains , Macrolides/pharmacologie , Nitrosourées/pharmacologie , Composés organiques du platine/pharmacologie , Taxoïdes/pharmacologie
15.
Br J Anaesth ; 118(6): 870-875, 2017 Jun 01.
Article de Anglais | MEDLINE | ID: mdl-28520886

RÉSUMÉ

BACKGROUND.: Strategies to achieve reductions in perioperative infections have focused on hand hygiene among anaesthestists but have been of limited efficacy. We performed a study in a simulated operating room to determine whether a barrier covering the anaesthesia workstation during induction and intubation might reduce the risk of contamination of the area and possibly, by extension, the patient. METHODS.: Forty-two attending and resident anaesthetists unaware of the study design were enrolled in individual simulation sessions in which they were asked to induce and intubate a human simulator that had been prepared with fluorescent marker in its oropharynx as a marker of potentially pathogenic bacteria. Twenty-one participants were assigned to a control group, whereas the other 21 performed the simulation with a barrier device covering the anaesthesia workstation. After the simulation, an investigator examined 14 target sites with an ultraviolet light to assess spread of the fluorescent marker of contamination to those sites. RESULTS.: The difference in rates of contamination between the control group and the barrier group was highly significant, with 44.8% (2.5%) of sites contaminated in the control group vs 19.4% (2.6%) of sites in the barrier group ( P <0.001). Several key clinical sites showed significant differences in addition to this overall decrement. CONCLUSIONS.: The results of this study suggest that application of a barrier device to the anaesthesia workstation during induction and intubation might reduce contamination of the intraoperative environment.


Sujet(s)
Anesthésie , Contamination de matériel/prévention et contrôle , Blocs opératoires/organisation et administration , Anesthésiologie/méthodes , Colorants fluorescents , Humains , Prévention des infections , Formation par simulation
16.
Obes Sci Pract ; 3(1): 106-114, 2017 03.
Article de Anglais | MEDLINE | ID: mdl-28392937

RÉSUMÉ

OBJECTIVES: This study examines the hypothesis that lower adipose tissue lipoprotein lipase (LPL) activity and a limited capacity for subcutaneous adipocyte expansion will be associated with metabolic syndrome (MSyn) in postmenopausal women who are overweight and obese. METHODS: Women (N = 150; age 60 ± 1 year; BMI: 31.5 ± 0.3 kg m-2; mean ± standard errors of the means [SEM]) with and without MSyn had dual-energy X-ray absorptiometry scans for total body fat, CT scans for visceral and subcutaneous abdominal adipose tissue areas, lipid and glucose metabolic profiles, and abdominal and gluteal fat aspirations for subcutaneous fat cell weight (FCW; N = 150) and LPL activity (N = 100). RESULTS: Women with MSyn had similar total body fat, but 15% larger abdominal and 11% larger gluteal FCWs and more visceral fat (179 ± 7 vs. 134 ± 6 cm2) than women without MSyn (P's < 0.05). Abdominal LPL activity was 13% (P = 0.18) lower in women with than without MSyn and correlated with abdominal FCW (r = 0.49, P < 0.01) only in those without MSyn. Visceral fat and abdominal and gluteal FCWs correlated with MSyn components, and subcutaneous adipose tissue correlated with abdominal FCW (r = 0.43, P < 0.01) and LPL activity (r = 0.18, P < 0.05), independent of total body fat. CONCLUSIONS: These results show that women with MSyn have lower LPL activity, limited capacity for subcutaneous adipocyte lipid storage and greater ectopic fat accumulation in viscera than women without MSyn of comparable obesity. This suggests that the development of novel therapies that would enhance adipocyte expandability might prevent the accumulation of ectopic fat and reduce the risk for MSyn in postmenopausal women with obesity.

17.
Regen Eng Transl Med ; 3(2): 94-105, 2017 Jun.
Article de Anglais | MEDLINE | ID: mdl-29457125

RÉSUMÉ

Dental caries (tooth decay) is the most common chronic disease. Dental tissue engineering is a promising alternative approach to alleviate the shortcomings of the currently available restorative materials. Mimicking the natural extracellular matrix (ECM) could enhance the performance of tissue engineering scaffolds. In this study, we developed microtubular (~20 µm diameter) polymethyl methacrylate (PMMA) scaffolds resembling the tubular (~2.5 µm diameter) structure of dentin, the collagen-based mineralized tissue that forms the major portion of teeth, to study the effect of scaffold architecture on differentiation of mouse dental pulp cells in vitro. Flat (control), plasma-treated solid and microtubular PMMA scaffolds with densities of 240±15, 459±51 and 480±116 tubules/mm2 were first characterized using scanning electron microscopy and contact angle measurements. Dental pulp cells were cultured on the surface of the scaffolds for up to 21 days and examined using various assays. Cell proliferation and mineralization were examined using Alamar Blue and Xylenol Orange (XO) staining assays, respectively. The differentiation of pulp cells into odontoblasts was examined by immunostaining for Nestin and by quantitative PCR analysis for dentin matrix protein 1 (Dmp1), dentin sialophosphoprotein (Dspp) and osteocalcin (Ocn). Our results showed that the highest tubular density scaffolds significantly (p<0.05) enhanced differentiation of pulp cells into odontoblasts as compared to control flat scaffolds, as evidenced by increased expression of Nestin (5.4x). However, mineralization was suppressed on all surfaces, possibly due to low cell density. These results suggest that the microtubular architecture may be a desirable feature of scaffolds developed for clinical applications. LAY SUMMARY: Regenerative engineering of diseased or traumatized tooth structure could avoid the deficiencies of traditional dental restorative (filling) materials. Cells in the dental pulp have the potential to differentiate to dentin-producing odontoblast cells. Furthermore, cell-supporting scaffolds that mimic a natural extracellular matrix (ECM) are known to influence behavior of progenitor cells. Accordingly, we hypothesized that a dentin-like microtubular scaffold would enhance differentiation of dental pulp cells. The hypothesis was proven true and differentiation to odontoblasts increased with increasing density of the microtubules. However, mineralization was suppressed, possibly due to a low density of cells. The results demonstrate the potential benefits of a microtubular scaffold design to promote odontoblast cells for regeneration of dentin.

18.
Am J Transplant ; 17(3): 703-711, 2017 03.
Article de Anglais | MEDLINE | ID: mdl-27539748

RÉSUMÉ

De novo donor-specific antibodies (dnDSAs) that develop after renal transplantation are independent predictors of allograft loss. However, it is unknown if dnDSA C1q status or titer at the time of first detection can independently predict allograft loss. In a consecutive cohort of 508 renal transplant recipients, 70 developed dnDSAs. Histologic and clinical outcomes were correlated with the C1q assay or dnDSA titer. C1q positivity correlated with dnDSA titer (p < 0.01) and mean fluorescence intensity (p < 0.01) and was more common in class II versus class I dnDSAs (p < 0.01). C1q status correlated with tubulitis (p = 0.02) and C4d status (p = 0.03) in biopsies at the time of dnDSA development, but not T cell-mediated rejection (TCMR) or antibody-mediated rejection (ABMR). De novo DSA titer correlated with Banff g, i, t, ptc, C4d scores, TCMR (p < 0.01) and ABMR (p < 0.01). Post-dnDSA graft loss was observed more frequently in recipients with C1q-positve dnDSA (p < 0.01) or dnDSA titer ≥ 1:1024 (p ≤ 0.01). However, after adjustment for clinical phenotype and nonadherence in multivariate models, neither C1q status nor dnDSA titer were independently associated with allograft loss, questioning the utility of these assays at the time of dnDSA development.


Sujet(s)
Complément C1q/immunologie , Rejet du greffon/étiologie , Survie du greffon/immunologie , Alloanticorps/immunologie , Défaillance rénale chronique/chirurgie , Transplantation rénale/effets indésirables , Donneurs de tissus , Adulte , Allogreffes , Femelle , Études de suivi , Débit de filtration glomérulaire , Humains , Alloanticorps/sang , Tests de la fonction rénale , Mâle , Pronostic , Facteurs de risque , Taux de survie , Receveurs de transplantation
19.
Med. intensiva ; 34(2): [1-12], 2017. tab
Article de Espagnol | LILACS | ID: biblio-883453

RÉSUMÉ

El manejo del síndrome de abstinencia alcohólica es un desafío en los pacientes críticos. Con frecuencia, se desconocen los antecedentes de consumo de alcohol o este dato es incompleto, lo que limita la identificación de quienes pueden desarrollar este síndrome. El cese abrupto del consumo de alcohol coloca a estos pacientes en alto riesgo de sufrir síndrome de abstinencia alcohólica grave. Típicamente, las benzodiacepinas son consideradas las drogas de primera línea para el manejo de estos casos. Sin embargo, si el paciente progresa a un estado más grave con convulsiones o delirium tremens, puede ser necesario administrar medicación adyuvante a las benzodiacepinas, como el propofol o la dexmedetomidina, o emplear estas últimas drogas como terapias alternativas en aquellos que no responden a las benzodiacepinas. La aparición de convulsiones representa un fuerte factor de riesgo para la progresión a un síndrome de abstinencia alcohólica grave, con el desarrollo posterior de delirium tremens hasta en el 30% de los casos. El delirium tremens es el cuadro más grave y ocurre en el 5-20% de los pacientes con este síndrome, con una mortalidad hasta del 25% sin tratamiento y que se reduce al 0-1% con tratamiento. Es importante conocer el antecedente del consumo de alcohol para evitar el síndrome de abstinencia alcohólica o tratar rápidamente sus síntomas más graves, y mejorar la supervivencia de estos pacientes.(AU)


Alcohol withdrawal syndrome (AWS) is a well-known and a challenging condition occurring in critically ill patients. Frequently, history of alcohol abuse is unknown when the patient is admitted to the intensive care unit, limiting the identification of those who could develop AWS. The abrupt cessation of a heavy or constant drinking put these patients in high risk of suffering from this syndrome in its severe form. Typically, benzodiazepines are considered the first line of treatment. However, if clinical conditions progress to epileptic seizures or delirium tremens or are refractory to benzodiazepines, adjuvant drugs like propofol or dexmedetomidine might be an option to control the severe symptoms. Delirium tremens can occur in up to 30% of patients; it is the most severe picture with a mortality of 25% without treatment and that can be reduced to almost 0-1% with treatment. It is important to appropriately identify alcohol abuse in order to avoid the early clinical manifestations of AWS or rapidly treat its most severe symptoms and improve survival.(AU)


Sujet(s)
Humains , Délirium trémens/traitement médicamenteux , Abstinence alcoolique , Benzodiazépines , Soins de réanimation
20.
Bone Joint J ; 98-B(10): 1418-1424, 2016 Oct.
Article de Anglais | MEDLINE | ID: mdl-27694599

RÉSUMÉ

AIMS: Smoking is associated with post-operative complications but smokers often under-report the amount they smoke. Our objective was to determine whether a urine dipstick test could be used as a substitute for quantitative cotinine assays to determine smoking status in patients. PATIENTS AND METHODS: Between September 2013 and July 2014 we conducted a prospective cohort study in which 127 consecutive patients undergoing a planned foot and ankle arthrodesis or osteotomy were included. Patients self-reported their smoking status and were classified as: 'never smoked' (61 patients), 'ex-smoker' (46 patients), or 'current smoker' (20 patients). Urine samples were analysed with cotinine assays and cotinine dipstick tests. RESULTS: There was a high degree of concordance between dipstick and assay results (Kappa coefficient = 0.842, p < 0.001). Compared with the quantitative assay, the dipstick had a sensitivity of 88.9% and a specificity of 97.3%. Patients claiming to have stopped smoking just before surgery had the highest rate of disagreement between reported smoking status and urine testing. CONCLUSION: Urine cotinine dipstick testing is cheap, fast, reliable, and easy to use. It may be used in place of a quantitative assay as a screening tool for detecting patients who may be smoking. A positive test may be used as a trigger for further assessment and counselling. Cite this article: Bone Joint J 2016;98-B:1418-24.


Sujet(s)
Cotinine/urine , Maladies articulaires/chirurgie , Procédures orthopédiques , Fumer/urine , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Femelle , Études de suivi , Humains , Incidence , Mâle , Adulte d'âge moyen , Période préopératoire , Études prospectives , Facteurs de risque , Autorapport , Fumer/épidémiologie , Facteurs temps , Royaume-Uni/épidémiologie , Examen des urines , Jeune adulte
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...